The cytotoxic T-lymphocyteassociatedantigen 4 (CTLA-4) and programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) have been observed to block TILs and to promote tumor growth and progression (18). Here, CD274 is linked to neoplasm.